Thompson Investment Management Inc. boosted its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 74.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,500 shares of the company’s stock after buying an additional 5,750 shares during the quarter. Thompson Investment Management Inc.’s holdings in Henry Schein were worth $1,107,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HSIC. Alecta Pensionsforsakring Omsesidigt raised its position in Henry Schein by 112.0% in the 3rd quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock valued at $435,693,000 after buying an additional 2,806,990 shares during the last quarter. Janus Henderson Group PLC grew its stake in Henry Schein by 394.1% in the 2nd quarter. Janus Henderson Group PLC now owns 1,465,303 shares of the company’s stock valued at $268,173,000 after purchasing an additional 1,168,763 shares during the period. Swedbank grew its stake in Henry Schein by 84.9% in the 3rd quarter. Swedbank now owns 2,358,594 shares of the company’s stock valued at $193,381,000 after purchasing an additional 1,083,115 shares during the period. Bank of New York Mellon Corp grew its stake in Henry Schein by 102.9% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,529,279 shares of the company’s stock valued at $125,387,000 after purchasing an additional 775,483 shares during the period. Finally, Fisher Asset Management LLC grew its stake in Henry Schein by 99.3% in the 3rd quarter. Fisher Asset Management LLC now owns 844,106 shares of the company’s stock valued at $69,208,000 after purchasing an additional 420,637 shares during the period. 53.07% of the stock is owned by institutional investors and hedge funds.
A number of research analysts have issued reports on the company. BidaskClub downgraded Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday, August 2nd. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Piper Jaffray Companies upgraded Henry Schein from a “neutral” rating to an “overweight” rating in a research note on Friday, September 15th. UBS AG restated a “buy” rating on shares of Henry Schein in a research note on Friday, September 15th. Finally, Jefferies Group LLC restated a “hold” rating and issued a $88.50 price objective on shares of Henry Schein in a research note on Friday, July 21st. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $89.88.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Monday, November 6th. The company reported $0.87 earnings per share for the quarter, missing the consensus estimate of $0.90 by ($0.03). The firm had revenue of $3.16 billion for the quarter, compared to the consensus estimate of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The firm’s revenue was up 10.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.84 EPS. analysts predict that Henry Schein, Inc. will post 3.6 EPS for the current fiscal year.
Henry Schein declared that its Board of Directors has approved a stock repurchase program on Monday, September 18th that authorizes the company to repurchase $400.00 million in shares. This repurchase authorization authorizes the company to buy up to 6.3% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s leadership believes its shares are undervalued.
In other Henry Schein news, SVP Paul Rose sold 2,126 shares of the firm’s stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the completion of the transaction, the senior vice president now owns 17,841 shares in the company, valued at approximately $3,077,750.91. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.19% of the stock is currently owned by corporate insiders.
WARNING: This report was published by Markets Daily and is owned by of Markets Daily. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at https://www.themarketsdaily.com/2017/11/16/thompson-investment-management-inc-has-1-11-million-position-in-henry-schein-inc-hsic.html.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.